OncoLens is an oncology-focused treatment planning platform used regularly by more than 200 Cancer Centers in the U.S. This broad network, combined with AI/NLP technology which identifies appropriate patients creates a premier patient identification and enrollment tool. Once an eligible patient is identified, the provider team is alerted within the planning platform—a unique feature! “Brief Description of Innovative Technology” OncoLens’ proprietary AI/NLP searches structured and unstructured data within EMR systems, identifying even challenging genomic data often stored in unstructured PDFs. Once patients are identified, providers are notified via OncoLens’ planning platform. This makes OncoLens an end-to-end solution, eliminating critical communication gaps when patients are identified but the entire care team may be unaware.
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…